MannKind set for opening gap up

|About: MannKind Corporation (MNKD)|By:, SA News Editor

Shares of MannKind (MNKD) are up 19% premarket on healthy volume as investors get ready for the first full day of trading after the FDA announced its approval of Afrezza on Friday. Shares initially sold off but recovered a good bit of the down move. The closing price was $10.00 out of a range of $8.20 - 11.11 on turnover of 39.7M shares (4x normal volume).